Artificial Intelligence | Machine Learning Curi Bio | Integrating Human iPSC-Derived Cells


Enterprise, Biotechnology, Drug Discovery, Medical Devices, Data Analytics, Therapeutic, Cell Biology Seattle, WA, United States

Curi Bio

Artificial Intelligence | Machine Learning


Curi Bio | Integrating Human iPSC-Derived Cells

Curi Bio

Biotechnology, Drug Discovery, Medical Devices, Data Analytics, Therapeutic, Cell Biology


Seattle, WA, United States

Curi Bio provides seamless, bioengineered integration of human cells, systems, and data to accelerate the discovery of new medicines. Curi’s suite of human stem cell-based products and services enable scientists to build mature and predictive human iPSC-derived tissues, with a focus on cardiac, musculoskeletal, and neuromuscular models for discovery, safety testing, and efficacy testing of new therapeutics.

By offering drug developers an integrated platform comprising highly predictive human iPSC-derived cells and tissues and clinically-relevant data, Curi aims to dramatically accelerate the discovery and development of safer, more effective medicines.

 

B2B

26 to 50

Series A

$16 M

Scaling Up

2015

 
 

Medical Devices
Biotechnology

Improve Discovery/Safety & Efficacy

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning


Biotechnology

Biotechnology


N/A

 

   Software


Python

Python

Java

Java

C/C++

C/C++


Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

Principal Electrical Engineer

Seattle, WA

Cardiac Stem Cell Scientist (PhD Level)

Seattle, WA

 

AI/ML Professionals

Want to work at Curi Bio?

We can introduce you to the right person at Curi Bio

Talk to our Talent Team

 

3

1

$10M

Company was founded 2015 and it took almost 7 years (Jan 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

01/03/2022

Series A

$10M

UTC Investment, DS Asset Management, Dynamk Capital

Date : 01/03/2022

Round: Series A

$ Raised: $10M

Investors: UTC Investment, DS Asset Management, Dynamk Capital

 

Investors

Interested in researching Curi Bio?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Curi Bio

Request a Demo - Deal Souring Platform

 
Nicholas Geisse


Nicholas Geisse
Chief Science Officer

Elliot Fisher


Elliot Fisher
Co-Founder & Chief Business Officer

Michael Cho


Michael Cho
CEO

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Curi Bio